(Q40069536)

17 September 2017

Lack of association between AKT1 variances versus clinical manifestations and social function in patients with schizophrenia (English)

1 reference

17 September 2017

0 references

Y C Liu

1

1 reference

17 September 2017

C L Huang

2

1 reference

17 September 2017

P L Wu

3

1 reference

17 September 2017

Y C Chang

4

1 reference

17 September 2017

C H Huang

5

1 reference

17 September 2017

H Y Lane

6

1 reference

17 September 2017

language of work or name

English

0 references

publication date

17 July 2008

1 reference

Journal of Psychopharmacology

17 September 2017

1 reference

17 September 2017

23

1 reference

17 September 2017

8

1 reference

17 September 2017

937-943

1 reference

Positive and negative symptoms in schizophrenia. A critical reappraisal

17 September 2017

1 reference

https://api.crossref.org/works/10.1177%2F0269881108093840

Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108093840

Lithium activates the serine/threonine kinase Akt-1 and suppresses glutamate-induced inhibition of Akt-1 activity in neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108093840

The functional significance of social cognition in schizophrenia: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108093840

Genes for schizophrenia and bipolar disorder? Implications for psychiatric nosology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108093840

Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108093840

The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108093840

The FOCIS international survey on psychiatrists' opinions on cognition in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108093840

Genes for schizophrenia? Recent findings and their pathophysiological implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108093840

Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108093840

Failure to support a genetic contribution of AKT1 polymorphisms and altered AKT signaling in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108093840

The positive and negative syndrome scale (PANSS) for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108093840

Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108093840

Akt1 deficiency affects neuronal morphology and predisposes to abnormalities in prefrontal cortex functioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108093840

Association of risperidone treatment response with a polymorphism in the 5-HT(2A) receptor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108093840

Effects of dopamine D2 receptor Ser311Cys polymorphism and clinical factors on risperidone efficacy for positive and negative symptoms and social function

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108093840

Pharmacogenetic studies of response to risperidone and other newer atypical antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108093840

DRD2 promoter region variation as a predictor of sustained response to antipsychotic medication in first-episode schizophrenia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108093840

Absence of significant associations between four AKT1 SNP markers and schizophrenia in the Taiwanese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108093840

Ethnic heterogeneity in allele variation in the DRD4 gene in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108093840

Phosphatidylinositol 3-kinase: a molecule mediating BDNF-dependent spatial memory formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108093840

Association analysis of AKT1 and schizophrenia in a UK case control sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108093840

AKT1 and neurocognition in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108093840

Schizophrenia: diverse approaches to a complex disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108093840

Molecular cloning of the akt oncogene and its human homologues AKT1 and AKT2: amplification of AKT1 in a primary human gastric adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108093840

AKT1 is associated with schizophrenia across multiple symptom dimensions in the Irish study of high density schizophrenia families

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108093840

Control of synaptic strength, a novel function of Akt.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108093840

A summary statistic approach to sequence variation in noncoding regions of six schizophrenia-associated gene loci.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108093840

An efficient procedure for genotyping single nucleotide polymorphisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108093840

The role of DTNBP1, NRG1, and AKT1 in the genetics of schizophrenia in Finland

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108093840

Association of AKT1 gene polymorphisms with risk of schizophrenia and with response to antipsychotics in the Chinese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108093840

21 January 2018

Identifiers

DOI

10.1177/0269881108093840

1 reference

17 September 2017

1 reference